There are 210 resources available
Immunogenicity of neoepitopes
Presenter: Diego Chowell
Session: Cancer neoantigens
Proffered Paper session III - Invited Discussant LBA1 and 50O
Presenter: John Haanen
Session: Proffered Paper session III
Proffered Paper session III - Invited Discussant LBA4 and 49O
Presenter: Solange Peters
Session: Proffered Paper session III
Novel immune combinations for genitourinary cancers
Presenter: Charles Drake
Session: What’s new in genitourinary (GU) tumours
Resources:
Presentation
Firstline immune therapy in clear cell renal cancer
Presenter: Laurence Albiges
Session: What’s new in genitourinary (GU) tumours
Resources:
Presentation
Webcast
Directing the immune system with neoantigen therapeutics
Presenter: Richard Gaynor
Session: Immuno-oncology: State of the art I
Resources:
Presentation
Arginase inhibition to modulate the TME: Rationale and early clinical experience
Presenter: Sonia Ioannidis
Session: Immuno-oncology: State of the art I
Resources:
Presentation
When 1+1 = 3: Unlocking the potential of the IL-2 pathway with NKTR-214 in combination treatment
Presenter: Jonathan Zalevsky
Session: Immuno-oncology: State of the art I
Resources:
Presentation
Webcast
ImmTACTM Platform: Novel bispecific high affinity TCR-effector fusions to modulate the immune system for the treatment of cancer
Presenter: Laure Humbert
Session: Immuno-oncology: State of the art I
Resources:
Presentation
Webcast
Biomarkers for immune therapy in urology cancer: Fact or fiction
Presenter: Thomas Powles
Session: What’s new in genitourinary (GU) tumours
Resources:
Presentation
Webcast